Imidazole → HCID 13726519, compound
Reaction equation
Cl[CH2:2][CH2:3][CH:4]1[CH2:10][N:9]([CH3:11])[C:8](=[O:12])[C:7]2[CH:13]=[CH:14][CH:15]=[N:16][C:6]=2[O:5]1.[NH:17]1[CH:21]=[CH:20][N:19]=[CH:18]1>CN(C)C=O>[N:17]1([CH2:2][CH2:3][CH:4]2[CH2:10][N:9]([CH3:11])[C:8](=[O:12])[C:7]3[CH:13]=[CH:14][CH:15]=[N:16][C:6]=3[O:5]2)[CH:21]=[CH:20][N:19]=[CH:18]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 130 °C
Procedure
To a solution of 2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f][1,4]-oxazepine-5(4H)-one, 9.12 g (0.038 mole) in dimethylformamide (30 ml) was added imidazole, 5.66 g (0.083 mole). The solution was heated to 130° C. for 18 hr. Dimethylformamide was removed by rotary evaporation (80° C., vacuum pump) and the residue taken up in chloroform (100 ml). The chloroform was washed with dilute aqueous sodium hydroxide (30 ml), dried over sodium sulfate and concentrated by rotary evaporation (70° C., water aspirator) to an oil. Crystallization was induced with ethanol. White crystals, 1.5 g (14.5%) were collected, m.p. 150°-152° C.
Workup
- customDimethylformamide was removed by rotary evaporation (80° C., vacuum pump)
- washThe chloroform was washed with dilute aqueous sodium hydroxide (30 ml)
- dry with materialdried over sodium sulfate
- concentrationconcentrated by rotary evaporation (70° C., water aspirator) to an oil
- customCrystallization
- customWhite crystals, 1.5 g (14.5%) were collected
Sources & evidence
- ORD record
- ord-8ea6e432756f4de58bd40bee934c1dd9
- Source dataset
- uspto-grants-1986_08
- Patent number
- US04604388
Reaction notes
Loading…